Effects of semaglutide on heart failure outcomes

Affiliations

¹ Cardiovascular R&D Centre - UnIC@RISE, Department of Surgery and Physiology, Faculty of Medicine of the University of Porto, Porto 4200-319, Portugal; Department of Endocrinology, Diabetes and Metabolism, ULS São João, Porto, Portugal. Electronic address: jsneves@med.up.pt.
² Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, TX, USA; Imperial College, London, UK.
³ Cardiovascular R&D Centre - UnIC@RISE, Department of Surgery and Physiology, Faculty of Medicine of the University of Porto, Porto 4200-319, Portugal; Université de Lorraine, Inserm, Centre d'Investigations Cliniques and Inserm U1116, CHRU Nancy, F-CRIN INI-CRCT, Nancy, France.

João Sérgio Neves et al. Lancet. 2025.

. 2025 Feb 15;405(10478):542-543.

doi: 10.1016/S0140-6736(24)02860-5.

¹ Cardiovascular R&D Centre - UnIC@RISE, Department of Surgery and Physiology, Faculty of Medicine of the University of Porto, Porto 4200-319, Portugal; Department of Endocrinology, Diabetes and Metabolism, ULS São João, Porto, Portugal. Electronic address: jsneves@med.up.pt.
² Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, TX, USA; Imperial College, London, UK.
³ Cardiovascular R&D Centre - UnIC@RISE, Department of Surgery and Physiology, Faculty of Medicine of the University of Porto, Porto 4200-319, Portugal; Université de Lorraine, Inserm, Centre d'Investigations Cliniques and Inserm U1116, CHRU Nancy, F-CRIN INI-CRCT, Nancy, France.

No abstract available

Publication types